DUBLIN–(BUSINESS WIRE)–The “Vimpat
– API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s
offering.

Vimpat – API Insight, 2019 provides product and API
manufacturers’ details across the globe along with the location. The
report gives the clear idea on the country wise DMF filed by worldwide
companies related to Vimpat. The report also highlights the patent
details of Vimpat.

Scope of the Report

• A comprehensive product overview including product description,
  regulatory milestones, safety, pharmacological properties, clinical
  trials, and product development activities have been elaborated in
  this report
• Patent information around Vimpat in United States (US) and Europe (EU)
  has been highlighted
• API manufacturers for Vimpat in United States, Europe, China and India
• The report contains historical and forecasted sales for Vimpat till
  2021
• Enlists the market competition and emerging therapies in the space
  where Vimpat operates

Reasons to Buy

• Evaluate the marketing status of Vimpat to exploit opportunities for
  generic Vimpat development opportunities
• Design effective counter-strategies to gain competitive advantage by
  identifying the key patent expiry details with respect to Vimpat
• API intelligence over Vimpat and gaining primary intelligence over
  Active Ingredient manufacturers by country
• Make more informed business decisions from insightful and in-depth
  analysis of the Vimpat’s performance

Key Topics Covered

1. Vimpat Overview

2. Vimpat Global Sales Assessment

• Vimpat Historical Global Sales
• Vimpat Forecasted Global Sales

3. Product Description

• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties

4. Product Details by country

5. Patent Information

6. Global API Manufacturers Assessment

• Active Pharmaceutical Ingredient (API) Manufacturers by Country
• Active Pharmaceutical Ingredient (API) Manufacturers by Region

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/3kvytx

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Central
Nervous System Drugs

DUBLIN–(BUSINESS WIRE)–The “Vimpat
– API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s
offering.

Vimpat – API Insight, 2019 provides product and API
manufacturers’ details across the globe along with the location. The
report gives the clear idea on the country wise DMF filed by worldwide
companies related to Vimpat. The report also highlights the patent
details of Vimpat.

Scope of the Report

• A comprehensive product overview including product description,
  regulatory milestones, safety, pharmacological properties, clinical
  trials, and product development activities have been elaborated in
  this report
• Patent information around Vimpat in United States (US) and Europe (EU)
  has been highlighted
• API manufacturers for Vimpat in United States, Europe, China and India
• The report contains historical and forecasted sales for Vimpat till
  2021
• Enlists the market competition and emerging therapies in the space
  where Vimpat operates

Reasons to Buy

• Evaluate the marketing status of Vimpat to exploit opportunities for
  generic Vimpat development opportunities
• Design effective counter-strategies to gain competitive advantage by
  identifying the key patent expiry details with respect to Vimpat
• API intelligence over Vimpat and gaining primary intelligence over
  Active Ingredient manufacturers by country
• Make more informed business decisions from insightful and in-depth
  analysis of the Vimpat’s performance

Key Topics Covered

1. Vimpat Overview

2. Vimpat Global Sales Assessment

• Vimpat Historical Global Sales
• Vimpat Forecasted Global Sales

3. Product Description

• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties

4. Product Details by country

5. Patent Information

6. Global API Manufacturers Assessment

• Active Pharmaceutical Ingredient (API) Manufacturers by Country
• Active Pharmaceutical Ingredient (API) Manufacturers by Region

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/3kvytx

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Central
Nervous System Drugs